Literature DB >> 32472379

Microsurgical versus endoscopic trans-sphenoidal approaches for clivus chordoma: a pooled and meta-analysis.

Delia Cannizzaro1, Maria Pia Tropeano2, Davide Milani1, Riccardo Spaggiari1, Ismail Zaed1, Cristina Mancarella3, Giovanni Battista Lasio1, Maurizio Fornari1, Franco Servadei1, Andrea Cardia1.   

Abstract

Chordoma is a rare slow-growing neoplastic bone lesion. However, they show an invasive local growth and high recurrence rate, leading to an overall survival rate of 65% at 5 years and 35% at 10 years. We conducted a pooled and meta-analysis comparing recurrence rate, post-operative-complications, and survival in patients undergoing either microsurgical (MA) or endoscopic approaches (EA). Search of literature was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to identify surgical series of clivus chordomas published between January 1990 and March 2018 on Pubmed, Scopus, and Cochrane. Two different statistical analyses have been performed: a pooled analysis and a single-arm meta-analysis of overall recurrence rate and subgroup meta-analysis of complications in the subgroups open surgery and endoscopic surgery. After full-text screening, a total of 58 articles were included in the pooled analysis and 27 studies were included for the study-level meta-analysis. Pooled analysis-the extent of resection was the only association that remained significant (subtotal: HR = 2.18, p = 0.004; partial: HR = 4.40, p < 0.001). Recurrence was more prevalent among the surgical patients (45.5%) compared to endoscopic ones (23.7%). Meta-analysis-results of the cumulative meta-analysis showed an overall rate of recurrence of 25.6%. MA recurrence rate was 31.8% (99% CI 14-52.8), EA recurrence rate was 19.4% (5.4-39.2). CSF leak rate for the endoscopic group was 10.3% (99%CI 5-17.3) and 9.5% (99%CI 1.2-24.6) for the open surgery group. The partial removal versus total removal has an influence on recurrence rate (p < 0.001). MA recurrence rate was 31.8%; EA recurrence rate was 19.4%. The extent of resection is confirmed as a statistically significant factor affecting the risk for recurrence both with the pooled analysis and with the meta-analysis. Meta-analysis demonstrated that older patients tend to recur more than young patients, especially in surgical group.

Entities:  

Keywords:  Chordoma; Clival chordoma; EEA; Endoscopic endonasal approach; Microsurgery; Recurrence

Mesh:

Year:  2020        PMID: 32472379     DOI: 10.1007/s10143-020-01318-y

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  15 in total

1.  Chordoma: incidence and survival patterns in the United States, 1973-1995.

Authors:  M L McMaster; A M Goldstein; C M Bromley; N Ishibe; D M Parry
Journal:  Cancer Causes Control       Date:  2001-01       Impact factor: 2.506

2.  Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.

Authors:  Debraj Mukherjee; Kaisorn L Chaichana; Ziya L Gokaslan; Oran Aaronson; Joseph S Cheng; Matthew J McGirt
Journal:  J Neurosurg Spine       Date:  2010-12-24

3.  Clival chordomas: considerations after 16 years of endoscopic endonasal surgery.

Authors:  Matteo Zoli; Laura Milanese; Rocco Bonfatti; Marco Faustini-Fustini; Gianluca Marucci; Giovanni Tallini; Corrado Zenesini; Carmelo Sturiale; Giorgio Frank; Ernesto Pasquini; Diego Mazzatenta
Journal:  J Neurosurg       Date:  2017-04-14       Impact factor: 5.115

4.  Incidence and survival patterns of cranial chordoma in the United States.

Authors:  Kyle J Chambers; Derrick T Lin; Josh Meier; Aaron Remenschneider; Marc Herr; Stacey T Gray
Journal:  Laryngoscope       Date:  2013-10-29       Impact factor: 3.325

5.  Building a global consensus approach to chordoma: a position paper from the medical and patient community.

Authors:  Silvia Stacchiotti; Josh Sommer
Journal:  Lancet Oncol       Date:  2015-02       Impact factor: 41.316

Review 6.  Clival chordomas: A pathological, surgical, and radiotherapeutic review.

Authors:  Juan C Fernandez-Miranda; Paul A Gardner; Carl H Snyderman; Kenneth O Devaney; William M Mendenhall; Carlos Suárez; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2013-10-04       Impact factor: 3.147

Review 7.  Chordomas: A Review.

Authors:  Bernard George; Damien Bresson; Philippe Herman; Sébastien Froelich
Journal:  Neurosurg Clin N Am       Date:  2015-07       Impact factor: 2.509

8.  Clival chordoma: a single-centre outcome analysis.

Authors:  Max Jägersberg; Amir El Rahal; Philipp Dammann; Doron Merkler; Damien Charles Weber; Karl Schaller
Journal:  Acta Neurochir (Wien)       Date:  2017-05-07       Impact factor: 2.216

Review 9.  Clivus chordomas: a systematic review and meta-analysis of contemporary surgical management.

Authors:  Moujahed Labidi; Kentaro Watanabe; Schahrazad Bouazza; Damien Bresson; Anne L Bernat; Bernard George; Sébastien Froelich
Journal:  J Neurosurg Sci       Date:  2016-06-15       Impact factor: 2.279

10.  Incidence and relative survival of chordomas: the standardized mortality ratio and the impact of chordomas on a population.

Authors:  Nicolas R Smoll; Oliver P Gautschi; Ivan Radovanovic; Karl Schaller; Damien C Weber
Journal:  Cancer       Date:  2013-03-15       Impact factor: 6.860

View more
  5 in total

Review 1.  Modern endoscopic skull base neurosurgery.

Authors:  Rafael Martinez-Perez; Luis C Requena; Ricardo L Carrau; Daniel M Prevedello
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

2.  The impact of expanded endoscopic approaches on oncologic and functional outcomes for clival malignancies:a case series.

Authors:  Franco DeMonte; Shaan M Raza; Solon Schur; Joel Z Passer; Ehab Y Hanna; Shirley Y Su; Michael E Kupferman
Journal:  J Neurooncol       Date:  2022-08-16       Impact factor: 4.506

3.  Augmented Reality in Neurosurgery, State of Art and Future Projections. A Systematic Review.

Authors:  Delia Cannizzaro; Ismail Zaed; Adrian Safa; Alice J M Jelmoni; Antonio Composto; Andrea Bisoglio; Kyra Schmeizer; Ana C Becker; Andrea Pizzi; Andrea Cardia; Franco Servadei
Journal:  Front Surg       Date:  2022-03-11

4.  Proteomics and phosphoproteomics of chordoma biopsies reveal alterations in multiple pathways and aberrant kinases activities.

Authors:  Jing Hang; Hanqiang Ouyang; Feng Wei; Qihang Zhong; Wanqiong Yuan; Liang Jiang; Zhongjun Liu
Journal:  Front Oncol       Date:  2022-09-30       Impact factor: 5.738

5.  Endoscopic endonasal approach for loco-regional recurrent clivus chordomas.

Authors:  Matteo Zoli; Federica Guaraldi; Davide Gori; Riccardo Cavicchi; Giacomo Sollini; Sofia Asioli; Marco Faustini-Fustini; Raffaele Agati; Raffaele Lodi; Caterina Tonon; Ernesto Pasquini; Diego Mazzatenta
Journal:  Brain Spine       Date:  2022-07-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.